Unit details
MLL393 - Health and Biotechnology Law
| Offered at: | (X) |
|---|---|
| Credit point(s): | 1 |
| Offerings: | Trimester 3 |
| EFTSL value: | 0.125 |
| Cohort rule: | (For Bachelor of Laws students only) |
| Unit chair: | S Allan |
| Prerequisite: | MLL213, MLL214, MLL323 and MLL405 |
| Corequisite: | Nil |
| Incompatible with: | Nil |
| Contact hours: | 3 x 1 hour lectures per week |
| Note: Online teaching methods require internet access. Please refer to the most current computer specifications. | |
Content
The unit aims to provide students with an understanding of the law relevant to the health system and the biotechnology industry. Health and biotechnology law is a rapidly growing discipline in Australia. Topics include: the legal framework of the Medicare system, the pharmaceutical industry and the biotechnology industry; medical negligence; confidentiality and privacy and access to medical records; genetics; end of life decision-making/euthanasia.
Assessment
Written Assignment 3000-4000 words 40%, Examination 2 hours 60%
Unit Fee Information
| Student Contribution Rate* | Student Contribution Rate** | Student Contribution Rate*** | Fee rate - Domestic Students | Fee rate - International students |
| $1178 | $1178 | $1178 | $2722 | $2846 |
* Student contribution rate for Commonwealth Supported students who commenced studies from 2010
** Student contribution rate for Commonwealth Supported students who commenced studies from 2009
*** Student contribution rate for Commonwealth Supported students who commenced studies from 2008
Please note: Unit fees listed do not apply to Deakin Prime students.
